Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Conferences
Videos
Webinars
Media & Press
Top Story
Kickback
Labcorp to pay $19M to settle kickback, false claims lawsuit
Labcorp has denied all allegations in the complaint and has not admitted liability as part of an executed settlement.
Featured
COVID-19
Vaccine effectiveness against Omicron variants may change over time
Guideline
Study suggests race adjustment unnecessary for alpha fetoprotein prenatal testing
Latest News
Long COVID significantly impacting workforce, according to analysis of workers' compensation claims
February 7, 2023
FDA grants 510k clearance, CLIA waiver for BioFire multiplex respiratory panel
February 7, 2023
Oxford BioDynamics announces study results for prostate screening blood test
February 7, 2023
New York State Department of Health approves PreciseDx breast cancer LDT
February 7, 2023
Business Insights
Emergency Use Authorization
LumiraDx obtains FDA authorization for test to detect flu A, flu B, SARS-CoV-2
Sequencing
Exact Sciences launches NGS test for cancer therapy selection
Guideline
Study suggests race adjustment unnecessary for alpha fetoprotein prenatal testing
Collaboration
Siemens Healthineers, Unilabs ink 200-million euro agreement
Diagnostic Technologies
Research and Development
Deepcell releases single-cell morphology data sets at AGBT general meeting
Collaboration
Siemens Healthineers, Unilabs ink 200-million euro agreement
Pathology and AI
3D spatial maps characterize biology enabling tumor growth: NIH director
Collaboration
Genetic Technologies, Qiagen forming strategic alliance
Diseases
COVID-19
Policy forum reviews NIH response to the COVID-19 pandemic
Cancer
Study evaluates clinical utility of Strata Oncology’s pan-tumor predictive biomarker
Guideline
Study suggests race adjustment unnecessary for alpha fetoprotein prenatal testing
Research and Development
Fluorescent RNA enables real time detection of neurodegenerative disease driver in live cells
More from LabPulse.com
LumiraDx obtains FDA authorization for test to detect flu A, flu B, SARS-CoV-2
The test leverages a single-step direct method for nucleic acid extraction and amplification on validated open RT-PCR instruments.
February 7, 2023
Exact Sciences launches NGS test for cancer therapy selection
The genomic test identifies tumor DNA and RNA alterations to generate a molecular picture of the patient's cancer. Test results are personalized for each patient to enable precise treatment.
February 7, 2023
Deepcell releases single-cell morphology data sets at AGBT general meeting
It generated the data sets using the Deepcell platform which leverages an artificial-intelligence model trained on millions of cell images.
February 6, 2023
Policy forum reviews NIH response to the COVID-19 pandemic
Successes in the COVID-19 research effort included improving diversity in clinical trials and prioritizing the evaluation of therapeutic agents, which enabled the rapid development of monoclonal antibodies and antiviral drugs.
February 3, 2023
Study evaluates clinical utility of Strata Oncology’s pan-tumor predictive biomarker
Based on a clinical study, investigators have described the performance of the company's pan-tumor predictive biomarker and its ability to guide checkpoint inhibitor immunotherapy.
February 7, 2023
Siemens Healthineers, Unilabs ink 200-million euro agreement
In the first years of the agreement, Siemens Healthineers will install high- and mid-volume immunoassay and clinical chemistry analyzers, including the Atellica Solution and Atellica CI 1900, sample handlers, hemostasis analyzers, and automation solution
February 2, 2023
Most Popular
Labcorp to pay $19M to settle kickback, false claims lawsuit
Vaccine effectiveness against Omicron variants may change over time
Quest Diagnostics Q4 revenues down 15% on COVID testing but base business grew
In pilot study, liquid biopsy test differentiates between localized and metastatic cancer to inform tailored treatment
Deepcell releases single-cell morphology data sets at AGBT general meeting
Siemens Healthineers, Unilabs ink 200-million euro agreement
More from LabPulse.com
Fluorescent RNA enables real time detection of neurodegenerative disease driver in live cells
Researchers have found an RNA structure associated with a neurodegenerative disease in live cells using a technique based on fluorescence-microscopic spectroscopy.
February 7, 2023
Simple HealthKit closes $8M in Series A financing
The Fremont, CA-based company said that its product portfolio includes diagnostic tests for sexual health, chronic conditions such as diabetes, and the tripledemic of COVID-19, respiratory syncytial virus (RSV), and influenza A and B.
February 6, 2023
In pilot study, liquid biopsy test differentiates between localized and metastatic cancer to inform tailored treatment
Cedars-Sinai Cancer researchers are developing a microfluidic device with a nanosurface as part of a blood test to inform treatment decisions.
February 3, 2023
Quest Diagnostics Q4 revenues down 15% on COVID testing but base business grew
Fourth-quarter COVID-19 testing revenues of $184 million dropped 75% compared to 2021, but base business revenues, excluding COVID sales, rose 6% year-over-year to $2.15 billion.
February 2, 2023
Hologic fiscal Q1 diagnostics revenues drop 27% on lower demand for COVID testing
Stephen MacMillan, Hologic chairman, president, and CEO, said he believes that the firm is well positioned for long-term growth while COVID testing declines.
February 2, 2023
Sepsis increases heart failure, rehospitalization risks following hospital discharge
Hospital patients who initially had or developed sepsis were at higher risk for heart failure, rehospitalization, or death within 12 years than patients without sepsis.
February 1, 2023